🇺🇸 FDA
Patent

US 12006522

Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

granted A61KA61K48/005A61K48/0058

Quick answer

US patent 12006522 (Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene) held by Precision BioSciences, Inc. expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Precision BioSciences, Inc.
Grant date
Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K48/005, A61K48/0058